Concepedia
Statistics
Publications
12
Citations
1.2K
H-Index
Active since
2000
Affiliations
Pfizer (United States)(Current)
State University of New York
Immune Pharmaceuticals (United States)
Boris Shor is an author at Pfizer (United States) specializing in oncology, mtor signaling, and mtor inhibition.
Publications per year
2000–2016
Biochemical, Cellular, and <i>In vivo</i> Activity of Novel ATP-Competitive and Selective Inhibitors of the Mammalian Target of Rapamycin
Ker Yu, Lourdes Toral‐Barza, Celine Shi et al. · Cancer Research · 2009 · 330 citations
Medicine, Oncology, Pharmacology +13
Beyond Rapalog Therapy: Preclinical Pharmacology and Antitumor Activity of WYE-125132, an ATP-Competitive and Specific Inhibitor of mTORC1 and mTORC2
Ker Yu, Celine Shi, Lourdes Toral‐Barza et al. · Cancer Research · 2010 · 208 citations · Full text
Medicine, Oncology, Pharmacology +14
Requirement of the mTOR Kinase for the Regulation of Maf1 Phosphorylation and Control of RNA Polymerase III-dependent Transcription in Cancer Cells
Boris Shor, Jiang Wu, Quazi Shakey et al. · Journal of Biological Chemistry · 2010 · 183 citations · Full text
Medicine, Molecular Biology, Oncology +16
A New Pharmacologic Action of CCI-779 Involves FKBP12-Independent Inhibition of mTOR Kinase Activity and Profound Repression of Global Protein Synthesis
Boris Shor, Weiguo Zhang, Lourdes Toral‐Barza et al. · Cancer Research · 2008 · 120 citations · Full text
Cpc2/RACK1 Is a Ribosome-associated Protein That Promotes Efficient Translation in Schizosaccharomyces pombe
Boris Shor, Jimmy Calaycay, Julie Ivory Rushbrook et al. · Journal of Biological Chemistry · 2003 · 87 citations · Full text
Life Sciences, Biochemistry, Molecular Biology +17
1–5 of 12